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 The prevalence of diabetes among adults in the United States has been 
rising from one period to the next (Cheng et al. 2013; Bullard et al. 2013) and 
from one birth cohort to the next (Fishman et al. 2014). The increase is evident 
whether assessed using self-reported data or measures of glycosylated 
hemoglobin (HbA1c) and fasting plasma glucose (FPG).  
 Estimates of diabetes incidence and prevalence are typically shown by age 
interval. By cumulating relevant data across age intervals, it is possible to 
estimate the likelihood of developing diabetes in the course of life, a readily 
understood concept that translates aggregate processes down to the level of an 
individual. Recent estimates of the lifetime probability of developing diabetes 
were presented in Gregg et al. (2014), following a strategy developed by Narayan 
et al. (2003). The estimates were based on self-reported data from the National 
Health Interview Surveys (Gregg et al. 2014). Individuals were asked if they had 
ever received a diagnosis of diabetes from their physician and if so at what age.  
 In this paper, we estimate the lifetime probability of developing diabetes in 
the United States by using HbA1c values, rather than self- reports, as the main 
criterion for identifying diabetes. These values are derived from National Health 
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and Nutrition Examination Surveys through 2010. This approach has the 
advantage of including undiagnosed cases of diabetes, which represent 
approximately 19% of total diabetes cases (Cowie et al. 2010). It has the 
additional advantage of using a stable criterion for the identification of diabetes. 
Ascertainment biases from increased screening, more permissive diagnostic 
criteria, and greater public awareness of the disease have been cited as 
contributors to sharply increased diabetes prevalence in the United States, United 
Kingdom and in Ontario (McBean et al. 2004; Holden et al. 2013; Lipscombe and 
Hux 2007). Using records from Medicare A and B, McBean et al. (2004) estimate 
that about a quarter of the 36% increase in diabetes prevalence over the period 
1992-93 to 2000-01  in the United States were attributable to changes in the 
algorithm used to detect individuals with diabetes. Incidence values are more 
vulnerable to ascertainment bias than are prevalence values because they include 
among new cases the influx of individuals who were not considered diabetic 
under old criteria but who are under new.  
Data and Methods 
 We employ data from NHANES III, 1988 to 1994 and from the Continuous 
NHANES (1999-2010). NHANES is a complex, multi-stage probability sample of the 
U.S. civilian non-institutionalized population. Participants complete a home 
interview and then are examined in a mobile examination center, which includes 
sampling participants’ blood for laboratory tests. The National Center for Health 
Statistics (NCHS) provides extensive documentation of NHANES survey, 
examination, and laboratory procedures on its website (NCHS 2012). 
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Characteristics of the NHANES study sample are reported elsewhere (Cheng et al. 
2013; Lee et al. 2010). 
 There were 88,224 individuals examined during our study periods. We 
exclude individuals below age 20, above age 80, or who were pregnant.  We also 
exclude subjects with missing HbA1c values. The final analytic sample for HbA1c-
based measures consists of 40,130 observations, with 7,011 observations from 
Phase 1 of NHANES III, 7,427 from Phase 2 of NHANES III, 7,778 from NHANES 
1999-2002, 7,755 from NHANES 2003-2006, and 10,159 from NHANES 2007-2010.  
 
Definition of diabetes 
 We define diabetes using the HbA1C criterion, which was first measured in 
NHANES III. This measure reflects average glycemia over a prolonged period and 
thus has more intra-subject stability than the leading alternative, measures of 
fasting plasma glucose (FPG) (Bonora et al. 2011). Furthermore, HbA1c-based 
measures of diabetes are more strongly associated with cardiovascular disease 
and death than are FPG-based measures (Selvin et al. 2010).  Finally, only 54% as 
many observations of diabetes status are available in NHANES using FPG as using 
HbA1c.   
 In accord with recommendations of the American Diabetes Association 
(2012), we define diabetes as HbA1c ≥ 6.5% (48 mmol/mol). Because diabetes 
medication is expected to reduce glycemia, the HbA1c values of medicated 
persons might not capture their diabetes status correctly. Therefore, individuals 
who reported taking diabetes medication are also considered diabetic. There 
were 896 individuals, or 19.2% of the group with diabetes, who reported taking 
diabetes medication and who had HbA1c ≤ 6.5%.  
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 We calculate each individual’s birth year using the equation Birth cohort = 
Period - Age.  To ensure large enough age-cohort cells, we analyze cohorts born in 
ten-year-wide intervals (1910 to 1919, 1920 to 1929, etc.). Using this approach, 
we obtain a total of 8 ten-year cohorts between 1910-1919 and 1980-1989. For 
details, see Fishman et al. (2014). 
 Prevalence is calculated as the proportion of individuals in the given age-
cohort cell with diabetes as defined above. Calculations are adjusted for complex 
survey design using strata and primary sampling units provided by the National 
Center for Health Statistics, along with survey weights. For HbA1c, we use the 
final examination weight provided by NCHS; because we pool adjacent data 
release cycles of Continuous NHANES, we divide the examination weights in 
Continuous NHANES by 2, as recommended by National Health and Nutrition 
Examination Survey (2006).  
 
Constructing a Multiple Decrement Life Table for the Diabetes-Free Population 
 In order to estimate the lifetime probability of developing diabetes, two 
data series are required: the age-specific rate of developing diabetes for a 
diabetes-free person; and the age-specific rate of death for a diabetes-free 
person. From these series, a multiple-decrement life table can be produced that 
tracks a diabetes-free birth cohort into either death or development of diabetes 
(Preston, Heuveline, and Guillot 2001: chapter 4). 
 A detailed description of our estimates of incidence is presented in Fishman 
et al. (2014). The logic of our approach was to infer incidence by observing 
changes in diabetes prevalence in a birth cohort as it progressed from one age to 
the next in successive waves of NHANES. Changes in prevalence in a birth cohort 
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from one age to the next were attributed to new cases of diabetes (incidence) 
and mortality differences between those with diabetes and those without. We 
thus assumed that migration into and out of the cohort does not affect the 
changes in prevalence; when we tested this assumption by including only native-
born individuals, results were similar. Those who develop diabetes are assumed 
remain in that state until death.  
 Rather than making separate estimates for each birth cohort, we allowed 
birth cohorts to “borrow strength” from one another by estimating an age-cohort 
model of the following type: 
 ln(Yia) = α +βaXa + βiXi , 
where Yia is the proportion of the population in cohort i at age a with diabetes, Xa 
is a dummy variable indicating that the observation pertains to age a, and Xi is a 
dummy variable indicating that the observation pertains to cohort i. This model 
implies that there is a standard age-pattern of diabetes prevalence, indicated by 
the Ba’s, that is scaled upwards or downwards by a scalar appropriate to each 
birth cohort and represented by the Bi’s. We used least squares to estimate the 
parameters of this model, which produced an R
2
 of 0.949.   
 For the current analysis, we use this model to predict prevalence at each 
age for each birth cohort and use the predicted prevalence to infer age-specific 
incidence. Our estimate of incidence uses the following formula: 
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xδ10  = rate of developing diabetes for a non-diabetic person in the age 
interval x to x+10, 
xΠ5 = prevalence of non-diabetes at ages x to x+5 
6 
 
xL5 = person-years lived between ages x and x+5 in a life table for the 
population (method described below) 
O
x
M L5 = person-years lived between ages x and x+5 in a life table for persons 
free of diabetes (method described below). 
 
 We interpret 
O
xδ10 as pertaining to the age interval x+2.5 to x+7.5, i.e. the 
five-year age span at the middle of the ten-year age interval x to x+10 (e.g. ages 
22.5 to 27.5, age 27.5 to 32.5, etc.). Values of xΠ5 pertaining to persons without 
diabetes are obtained as the complement of the prevalence values by age and 
cohort calculated from fitted values in the age-cohort model of prevalence in 
Fishman et al. (2014). We smooth the incidence series using a three-term moving 
average of 
O
xδ10  with the exception of the first (youngest) and last (oldest) values. 
We estimated these values for age groups 22.5 - 27.5 to 72.5- to 77.5. From ages 
20 to 22.5, we used the incidence value for ages 22.5-27.5. For ages above 77.5, 
we used the incidence value for ages 72.5 to 77.5.  We assumed that the 
incidence rate was constant within each five-year interval. For “boundary” ages 
(e.g. 27, 32) we used the average of the two adjacent incidence values.  
 Our mortality estimates are based on life tables for birth cohorts in the 
United States produced by the Social Security Administration (Bell and Miller 
2005). The basic life table that we use for the cohort born in years t to t+10 is the 
average of male and female life tables in years t and t+10.  To adapt this life table 
to the population without diabetes, we use NHANES to estimate the ratio of nLx 
columns for persons without diabetes to those of the entire population.  Life 
tables for individuals with and without diabetes are estimated using pooled data 
from NHANES III and Continuous NHANES (1999-2004 waves) cohorts linked to 
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deaths in the National Death Index through 2006. A discrete hazards model on a 
person-month file is employed to generate the underlying risks for predicting 
mortality rates. The model is implemented on baseline ages 20-74. There were 
2,903 deaths among 25,971 respondents.  Death rates in single-year intervals are 
derived from the 1Lx column of the composite life table for persons without 
diabetes in a particular birth cohort.  
 We complete the life table by adding up the two forces of decrement: 
 1mx = 1mx
death
 + 1mx
diabetes
 , and estimating the probability of leaving the 
diabetes-free population between ages x and x+1 as 
 1qx = 1 – exp(-nmx). The probability of exiting from diabetes is 
 1qx
diabetes
 = 1qx * (1mx
diabetes
/1mx) and the number of decrements is 
  
 dx
diabetes
 = 1qx
diabetes
 * l(x) 
Finally, the lifetime probability of developing diabetes for a diabetes-free person 
age 20 is 
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Results 
 Table 1 and Figure 1 present estimates of the probability that an individual 
from various birth cohorts will develop diabetes in the course of life. We estimate 
that a non-diabetic twenty-year old born during 1930-39 has a 30.4% chance of 
developing diabetes. If diabetes had not developed by age 50 for someone in this 
cohort, the probability of subsequently developing diabetes declines to 24.2%.  
Lifetime probabilities rise for later-born cohorts. For someone born a decade 
later, during 1940-49, the probability that a non-diabetic 20-year old will develop 
diabetes increases to 37.3%. Finally, for those individuals born between 1960-69, 
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the most recent cohort investigated, we estimate that the lifetime probability of 
developing diabetes is greater than half (54.8%).   
 It should be noted that the number of observed diabetes cases on which 
the cohort probabilities are based declines as the year of birth advances. The 
values for the cohort born 1960-69 are based on observations from ages 20 to 50. 
This is the age interval in which incidence rates are lowest and consequently 
estimates for this cohort are subject to the greatest error.  In contrast, estimates 
for the cohort born during 1940-49 are based on observations spanning ages 40 
to 70, and most of the cases of diabetes that we estimate will occur to this cohort 
have already been observed.   
 Reductions in mortality play a role in the increased probability of 
developing diabetes.  If the 1960-69 cohort were subjected to mortality 
conditions of the 1930-39 cohort instead of to their own conditions, we estimate 
that 50.9% of 20-year olds in the cohort would develop diabetes, compared to the 
actual cohort value of 54.8%. So reductions in mortality account for about .039 
(16%) of the .244 increase in the lifetime diabetes probability between the 1930-
39 and 1960-69 cohorts 
  
Discussion  
 Estimates by Gregg et al. use retrospective self-reported diagnoses of 
diabetes recorded in National Health Interview Surveys up to 2011. They  
estimate that a 20-year old male subject who experiences the incidence and 
mortality rates observed during 2000-2011 for all of his life had a 40.2% chance of 
developing diabetes, nearly identical to the 39.6% chance for a 20-year old 
woman. These values are based on “period rates” applied to a hypothetical 
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cohort. The most nearly comparable figures from estimates for actual birth 
cohorts apply to the cohort born during 1940-49, who spent the period 2000-
2010 in the ages of highest diabetes incidence from 50 to 70 (Fishman et al. 2014; 
Gregg et al. 2014). We estimate that 37.3% of this cohort will develop diabetes, 
close to the two-sex mean of 39.9% estimated by Gregg et al. Our figure is slightly 
lower than Gregg et al.’s, consistent with incidence rates being somewhat lower 
in earlier decades. Thus, it appears that estimates of the lifetime probability of 
developing diabetes based upon self-reports and a clinical measure of diabetes  
are mutually reinforcing.     
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Table 1. Probability of eventually developing 
diabetes at various ages 
  Birth cohort 
Age 1930-39 1940-49 1950-59 1960-69 
20 0.304 0.373 0.386 0.548 
25 0.302 0.371 0.383 0.545 
30 0.298 0.366 0.379 0.539 
35 0.292 0.359 0.371 0.528 
40 0.283 0.347 0.359 0.512 
45 0.266 0.327 0.339 0.484 
50 0.242 0.298 0.309 0.442 
55 0.211 0.258 0.268 0.384 
60 0.174 0.213 0.221 0.317 
65 0.140 0.170 0.177 0.254 
70 0.110 0.134 0.140 0.200 
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Figure 1. Probability of eventually 
developing diabetes, by birth cohort
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